Related Experiment Video
Updated: Jun 1, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose
Madhukar H Trivedi1, Tracy L Greer, Timothy S Church
1Division on Mood Disorders, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9119, USA. madhukar.trivedi@utsouthwestern.edu
Higher-dose aerobic exercise showed a trend toward improved remission rates for major depressive disorder (MDD) patients unresponsive to antidepressants. This exercise augmentation may be particularly beneficial for men and women without a family history of mental illness.
Area of Science:
- Psychiatry
- Exercise Science
- Clinical Psychology
Background:
- Major Depressive Disorder (MDD) often requires augmentation strategies beyond initial antidepressant treatment for remission.
- The Treatment with Exercise Augmentation for Depression (TREAD) study investigated aerobic exercise as a second-step treatment.
- A clinicaltrials.gov Identifier: NCT00076258.
Purpose of the Study:
- To test the efficacy of aerobic exercise as an augmentation treatment for MDD patients who did not achieve remission with selective serotonin reuptake inhibitor (SSRI) treatment.
- To compare the effects of two different exercise dosages (16 kcal per kg per week vs. 4 KKW) on depressive symptom remission.
- To explore potential moderating effects of gender and family history of mental illness on exercise treatment response.
Main Methods:
- A randomized controlled trial involving 126 sedentary adults (aged 18-70) diagnosed with nonpsychotic MDD and treated with SSRIs.
- Participants were randomized to augmentation with either 16 KKW or 4 KKW of aerobic exercise for 12 weeks, with SSRI treatment held constant.
- Remission was defined as a score ≤ 12 on the Inventory of Depressive Symptomatology, Clinician-Rated.
Main Results:
- A trend for higher remission rates was observed in the higher-dose exercise group (16 KKW) compared to the lower-dose group (4 KKW) (P < .06).
- The number needed to treat (NNT) for the higher-dose group was 7.8.
- Significantly higher remission rates were found for men (85.4% vs. 0.1%) and women without a family history of mental illness (39.0% vs. 5.6%) in the high-dose exercise group compared to the low-dose group.
Conclusions:
- Higher-dose aerobic exercise demonstrated a trend towards improved remission rates in MDD patients, with a clinically meaningful NNT.
- Significant benefits of higher-dose exercise were observed in men and in women without a family history of mental illness.
- These findings suggest that tailored exercise prescriptions, considering gender and family history, may enhance depression treatment outcomes.
Related Concept Videos
Electroconvulsive Therapy
Antidepressant Drugs: MAOIs and Other Agents

